Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
AKTX · NASDAQ · Pharmaceutical Preparations
$7.18+0.47 (+7.00%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Akari Therapeutics (AKTX) · oqro.io/stocks/AKTX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 13, 2026
MMCAP International Inc. SPC cut its AKTX stake below 5% (0.6%)Source5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 12, 2026
Bank of Montreal cut its AKTX stake below 5% (0.8%)SourceInsider trade · Traded Aug 21, 2025 · Filed Aug 29, 2025
CEO purchased ~$9.4K of AKTX shares in the open marketSourceInsider trade · Traded Aug 22, 2025 · Filed Aug 29, 2025
CEO purchased ~$7.4K of AKTX shares in the open marketSourceInsider trade · Traded Aug 25, 2025 · Filed Aug 29, 2025
CEO purchased ~$2.7K of AKTX shares in the open marketSourceInsider trade · Traded Jun 24, 2025 · Filed Jun 25, 2025
CEO purchased ~$6K of AKTX shares in the open marketSourceInsider trade · Traded Jun 23, 2025 · Filed Jun 25, 2025
CEO purchased ~$1.1K of AKTX shares in the open marketSourceInsider trade · Traded Jun 20, 2025 · Filed Jun 24, 2025
CEO purchased ~$12K of AKTX shares in the open marketSourceInsider trade · Traded Jun 17, 2025 · Filed Jun 20, 2025
CEO purchased ~$18K of AKTX shares in the open marketSource